Meeting Banner
Abstract #8023

Nanoparticulate Agents for Imaging in Diabetes

Anna Moore

Diabetes is a devastating disease hallmarked by high levels of blood glucose (hyperglycemia). While blood glucose measurement is considered a standard procedure for diabetic patients, it does not reflect a true status of functional beta cells and cannot be used for disease monitoring and evaluating the therapeutic response. The development of strategies for the noninvasive assessment of molecular events associated with diabetes constitutes an important healthcare priority. This presentation will focus on the development of imaging agents and techniques that could provide real time non-invasive data of biological parameters and their functions as they relate to diabetes progression and treatment.

This abstract and the presentation materials are available to members only; a login is required.

Join Here